Labour hire firm CoreStaff has settled a class action alleging it lured workers to Australia from Papua New Guinea with the promise of long-term work, […]
The Commonwealth Bank of Australia has been hit with a $45 million lawsuit by the Finance Sector Union for allegedly failing to provide thousands of employees with paid rest breaks for at least six years.
A court has made orders trimming the $990 hourly fee charged by a QC while representing Jo Dyer, a friend of the woman who accused Christian Porter of rape who succeeded in having silk Sue Chrysanthou removed from a defamation suit brought by the former attorney-general.
Trial plans in accused war criminal Ben Roberts-Smith’s defamation case against Nine have hit another roadblock because of COVID-19 restrictions, less than two weeks before the hearing is set to resume, with the media giant now suggesting a move to Western Australia.
The Australian Federal Police is cracking down on COVID-19 rapid antigen test price gouging, deploying a zero-tolerance strike team to investigate “outrageous” markups referred by the Australian Competition and Consumer Commission.
National Australia Bank has been served with a $78 million class action over the collapse of Walton Construction, three months after the case was stalled for funding complications.
The influence of an unvaccinated “iconic world tennis star” on the young and impressionable was not fanciful, the Full Federal Court has said in reasons for throwing out Novak Djokovic’s challenge to his deportation from Australia.
A law firm has escaped an order for costs sought by a Melbourne city council that argued the firm had turned a blind eye to a client’s lack of credibility in an unfair dismissal case.
The battle of the bunnies has begun as London-based soft toy designer Jellycat sues Kmart for stocking an alleged knockoff of its eminently popular ‘Bashful Bunny’ plush toy.
Israeli drug company Neurim Pharmaceuticals has won an eight month extension to apply for a grace period for its melatonin tablet patent to treat children with autism spectrum disorder after Australian company Generic Partners lost its “inherently implausible” opposition to the patent.